- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03684291
Hemodynamic Effects of Ventilation Modes
September 24, 2018 updated by: Hakan Yılmaz, Ufuk University
Effects of Two Different Ventilation Modes Used in Gynecologic Laparoscopic Operations Performed in Steep Trendelenburg Position on Hemodynamic Parameters
Different ventilation modes can be used in laparoscopic surgeries.
These surgeries are performed in steep Trendelenburg position with serious hemodynamic disturbances.
This study aims to observe the hemodynamic effects of two different ventilation modes in laparoscopic gynecologic surgery performed in steep Trendelenburg position.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Balgat
-
Ankara, Balgat, Turkey, 06520
- Recruiting
- UFUK UNIVERSITY FACULTY OF MEDICINE
-
Contact:
- Hakan Yılmaz, MD
- Phone Number: +903122044000
- Email: dr.hakanyilmaz@hotmail.com
-
Principal Investigator:
- Hakan Yılmaz, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women between 18 and 65 years of age scheduled to undergo elective gynecologic laparoscopic surgery
Description
Inclusion Criteria:
- Women of ASA I and II classification between 18-65 years scheduled for elective gynecologic laparoscopic surgery
Exclusion Criteria:
- Patient refusal to participate
- Patients with severe cardiac (congestive heart failure etc) and pulmonary (COPD, pulmonary hypertension) disease (ASA > III)
- Morbid obesity
- Negative Allen test
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group V
The patients in this group are ventilated using VCV (Volume Control Ventilation) mode (FiO2 50%, Tidal volume: 6-8 ml/kg (ideal body weight), frequency: 12/minute, I/E ratio: 1/2, PEEP not applied)
|
Adjustment of mechanical ventilation mode
|
|
Group P
The patients in this group are ventilated using PCV-VG (Volume Guaranteed Pressure Control Ventilation) mode (FiO2 50%, Tidal volume: 6-8 ml/kg (ideal body weight), frequency: 12/minute (EtCO2 kept between 35-40 mmHg), Pressure limit: 30 cm H2O, I/E:1/2, PEEP not applied)
|
Adjustment of mechanical ventilation mode
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of changes in MAP
Time Frame: T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
Mean arterial pressure (MAP) (mmHg)
|
T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
|
Measurement of changes in heart rate
Time Frame: T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
Heart rate (bpm)
|
T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
|
Measurement of changes in systemic vascular resistance index
Time Frame: T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
Systemic vascular resistance index (dyne x sec/cm2)
|
T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
|
Measurement of changes in stroke volume index
Time Frame: T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
Stroke volume index (mL/m2)
|
T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
|
Measurement of changes in cardiac index
Time Frame: T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
Cardiac index L(min x m2)
|
T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
|
Measurement of changes in stroke volume variation
Time Frame: T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
Stroke volume variation (%)
|
T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
|
Measurement of changes in cardiac cycle efficiency
Time Frame: T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
Cardiac cycle efficiency (units)
|
T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
|
Measurement of changes in aortic dp/dt
Time Frame: T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
Aortic dP/dt (mmHg/msec)
|
T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of changes in peak airway pressure
Time Frame: T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
Ppeak (Peak airway pressure)
|
T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
|
Measurement of changes in mean airway pressure
Time Frame: T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
Pmean (Mean Airway Pressure),
|
T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
|
Measurement of changes in plateau airway pressure
Time Frame: T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
Pplateau (Plateau Airway Pressure)
|
T0: Induction (Baseline) T1: Change after 30 minutes pneumoperitoneum T2: Change after desufflation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Balderi T, Forfori F, Marra V, Di Salvo C, Dorigo M, Anselmino M, Romano SM, Giunta F. Continuous hemodynamic monitoring during laparoscopic gastric bypass in superobese patients by pressure recording analytical method. Obes Surg. 2008 Aug;18(8):1007-14. doi: 10.1007/s11695-007-9379-5. Epub 2008 Apr 15.
- Liao CC, Kau YC, Ting PC, Tsai SC, Wang CJ. The Effects of Volume-Controlled and Pressure-Controlled Ventilation on Lung Mechanics, Oxidative Stress, and Recovery in Gynecologic Laparoscopic Surgery. J Minim Invasive Gynecol. 2016 Mar-Apr;23(3):410-7. doi: 10.1016/j.jmig.2015.12.015. Epub 2016 Jan 7.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
October 1, 2018
Primary Completion (Anticipated)
November 1, 2018
Study Completion (Anticipated)
November 15, 2018
Study Registration Dates
First Submitted
January 15, 2018
First Submitted That Met QC Criteria
September 24, 2018
First Posted (Actual)
September 25, 2018
Study Record Updates
Last Update Posted (Actual)
September 25, 2018
Last Update Submitted That Met QC Criteria
September 24, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- HemodynamicsTrendelenburg
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.